| DAA283 |
lactotransferrin |
Molecular |
kidney |
Human |
LTF |
115.0% Increase Gene Expression Level |
|
| DAA290 |
lysozyme (renal amyloidosis) |
Molecular |
kidney |
Human |
LYZ |
57.0% Increase Gene Expression Level |
|
| DAA266 |
matrix metallopeptidase 7 (matrilysin, uterine) |
Molecular |
kidney |
Human |
MMP7 |
23.0% Increase Gene Expression Level |
|
| DAA279 |
nicotinamide N-methyltransferase |
Molecular |
kidney |
Human |
NNMT |
40.0% Increase Gene Expression Level |
|
| DAA264 |
paraoxonase 3 |
Molecular |
kidney |
Human |
PON3 |
13.0% Decrease Gene Expression Level |
|
| DAA276 |
Rh family, C glycoprotein |
Molecular |
kidney |
Human |
RHCG |
16.0% Decrease Gene Expression Level |
|
| DAA278 |
Ras-related GTP binding D |
Molecular |
kidney |
Human |
RRAGD |
14.0% Decrease Gene Expression Level |
|
| DAA282 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
Molecular |
kidney |
Human |
SERPINA5 |
11.0% Decrease Gene Expression Level |
|
| DAA268 |
solute carrier family 12 (sodium/chloride transporters), member 3 |
Molecular |
kidney |
Human |
SLC12A3 |
16.0% Decrease Gene Expression Level |
|
| DAA286 |
StAR-related lipid transfer (START) domain containing 8 |
Molecular |
kidney |
Human |
STARD8 |
14.0% Decrease Gene Expression Level |
|
| DAA277 |
tyrosinase-related protein 1 |
Molecular |
kidney |
Human |
TYRP1 |
21.0% Decrease Gene Expression Level |
|
| DAA884 |
Widespread degeneration of glomerular blood vessels |
Physiological |
renal vasculature |
Human |
— |
— |
|
| DAA895 |
Basement membranes of glomeruli and tubules thicken |
Physiological |
renal tubule, glomerulus |
Human |
— |
— |
|
| DAA895 |
Basement membranes of glomeruli and tubules thicken |
Physiological |
renal tubule, glomerulus |
Human |
— |
— |
|
| DAA605 |
Bladder cancer |
Pathological |
bladder |
Human |
— |
SeriesMorbidity |
|
| DAA604 |
Cancer of kidney and renal pelvis |
Pathological |
urinary system |
Human |
— |
SeriesMorbidity |
|
| DAA1062 |
Creatinine clearance declines |
Physiological |
kidney |
Human |
— |
— |
|
| DAA881 |
Dietary protein required to induce renal sclerotic lesions decreases |
Physiological |
renal vasculature |
Human |
— |
— |
|
| DAA626 |
Essential (primary) hypertension and hypertensive renal disease |
Pathological |
heart, kidney |
Human |
— |
SeriesMorbidity |
|
| DAA639 |
Kidney diseases |
Pathological |
kidney |
Human |
— |
SeriesMorbidity |
|
| DAA880 |
Kidney mass gradually lost |
Physiological |
kidney |
Human |
— |
— |
|
| DAA887 |
Glomerular filtration rate declines |
Physiological |
glomerulus |
Human |
— |
— |
|
| DAA889 |
Glomeruli crowd together |
Physiological |
glomerulus |
Human |
— |
— |
|
| DAA888 |
Glomeruli number decreases |
Physiological |
glomerulus |
Human |
— |
— |
|
| DAA620 |
Hypertensive heart and renal disease |
Pathological |
heart, kidney |
Human |
— |
SeriesMorbidity |
|